RSS-Feed abonnieren
DOI: 10.1055/s-0039-3401037
Safety and Regulation of Fat Grafting
Funding None.Publikationsverlauf
Publikationsdatum:
15. Februar 2020 (online)
Abstract
Today, fat grafting has wide applicability across plastic surgery disciplines, including both aesthetic and reconstructive procedures. However, much controversy has surrounded adipose tissue transfer throughout the 20th century, necessitating extensive research to improve the fat grafting process and to better understand its associated complications and benefits. Initial concerns included the technical difficulties of properly handling and processing adipose to ensure adequate outcomes. As these issues were addressed, more modern concerns were raised by the U.S Food and Drug Administration and the general scientific community regarding the oncological potential of adipose tissue and its potential interference with breast cancer screenings. Today, many formalized clinical studies have evidenced the safety of fat grafting, allowing the procedure to gain widespread popularity and opening avenues for future applications.
Products/Devices/Drugs
None.
-
References
- 1 Neuber G. Ueber die Wiederanheilung vollständig vom Körper getrennter, die ganze Fettschicht enthaltender Hautstücke. Zbl F Chirurgie 1893; 30: 16
- 2 Mazzola RF, Mazzola IC. The fascinating history of fat grafting. J Craniofac Surg 2013; 24 (04) 1069-1071
- 3 Glicenstein J. Les premiers “fillers”, vaseline et paraffine. Du miracle à la catastrophe. Ann Chir Plast Esthet 2007; 52 (02) 157-161
- 4 Lexer E. Free transplantation. Ann Surg 1914; 60 (02) 166-194
- 5 Miller CC. Cannula implants and review of implantation technics in esthetic surgery. Chicago, IL: Oak Press; 1926
- 6 Al-Hayder S, Gramkow C, Trojahn Kølle S-F. Use of autologous fat grafting for the correction of burn scar contracture in the hand: a case report. Case Reports Plast Surg Hand Surg 2017; 4 (01) 81-83
- 7 Klinger M, Lisa A, Klinger F. , et al. Regenerative approach to scars, ulcers and related problems with fat grafting. Clin Plast Surg 2015; 42 (03) 345-352 , viii
- 8 No Authors. Report on autologous fat transplantation. ASPRS Ad-Hoc Committee on New Procedures, September 30, 1987. Plast Surg Nurs 1987; 7 (04) 140-141
- 9 Chajchir A, Benzaquen I. Fat-grafting injection for soft-tissue augmentation. Plast Reconstr Surg 1989; 84 (06) 921-934 , discussion 935
- 10 Coleman SR. The technique of periorbital lipoinfiltration. Oper Tech Plast Reconstr Surg 1994; 1 (03) 120-126
- 11 Coleman SR. Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg 1995; 19 (05) 421-425
- 12 Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg 1997; 24 (02) 347-367
- 13 Zuk PA, Zhu M, Ashjian P. , et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13 (12) 4279-4295
- 14 Rohrich RJ, Wan D. Making sense of stem cells and fat grafting in plastic surgery: the hype, evidence, and evolving U.S. Food and Drug Administration regulations. Plast Reconstr Surg 2019; 143 (02) 417e-424e
- 15 Yoshimura K, Shigeura T, Matsumoto D. , et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006; 208 (01) 64-76
- 16 Gutowski KA, Baker SB, Coleman SR. , et al; ASPS Fat Graft Task Force. Current applications and safety of autologous fat grafts: a report of the ASPS Fat Graft Task Force. Plast Reconstr Surg 2009; 124 (01) 272-280
- 17 Pierrefeu-Lagrange AC, Delay E, Guerin N, Chekaroua K, Delaporte T. Radiological evaluation of breasts reconstructed with lipomodeling [in French]. Ann Chir Plast Esthet 2006; 51 (01) 18-28
- 18 Pulagam SR, Poulton T, Mamounas EP. Long-term clinical and radiologic results with autologous fat transplantation for breast augmentation: case reports and review of the literature. Breast J 2006; 12 (01) 63-65
- 19 Cohen O, Lam G, Karp N, Choi M. Determining the oncologic safety of autologous fat grafting as a reconstructive modality: an institutional review of breast cancer recurrence rates and surgical outcomes. Plast Reconstr Surg 2017; 140 (03) 382e-392e
- 20 Hang-Fu L, Marmolya G, Feiglin DH. Liposuction fat-fillant implant for breast augmentation and reconstruction. Aesthetic Plast Surg 1995; 19 (05) 427-437
- 21 Khouri Jr RK, Khouri RK. Current clinical applications of fat grafting. Plast Reconstr Surg 2017; 140 (03) 466e-486e
- 22 Butterwick KJ, Bevin AA, Iyer S. Fat transplantation using fresh versus frozen fat: a side-by-side two-hand comparison pilot study. Dermatologic Surg 2006; 32 (05) 640-644
- 23 Gir P, Brown SA, Oni G, Kashefi N, Mojallal A, Rohrich RJ. Fat grafting: evidence-based review on autologous fat harvesting, processing, reinjection, and storage. Plast Reconstr Surg 2012; 130 (01) 249-258
- 24 Son D, Oh J, Choi T. , et al. Viability of fat cells over time after syringe suction lipectomy: the effects of cryopreservation. Ann Plast Surg 2010; 65 (03) 354-360
- 25 Wolter TP, von Heimburg D, Stoffels I, Groeger A, Pallua N. Cryopreservation of mature human adipocytes: in vitro measurement of viability. Ann Plast Surg 2005; 55 (04) 408-413
- 26 Krastev TK, Beugels J, Hommes J, Piatkowski A, Mathijssen I, van der Hulst R. Efficacy and safety of autologous fat transfer in facial reconstructive surgery: a systematic review and meta-analysis. JAMA Facial Plast Surg 2018; 20 (05) 351-360
- 27 Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006; 7 (12) 885-896
- 28 Yoshimura K, Sato K, Matsumoto D. Cell-assisted lipotransfer for breast augmentation: grafting of progenitor-enriched fat tissue. In: Shiffman MA. , ed. Autologous Fat Transfer: Art, Science, and Clinical Practice. Berlin, Heidelberg: Springer-Verlag; 2010
- 29 Mojallal A, Saint-Cyr M, Garrido I. Autologous fat transfer: controversies and current indications for breast surgery. J Plast Reconstr Aesthetic Surg 2009; 62 (05) 708-710
- 30 Charvet HJ, Orbay H, Harrison L, Devi K, Sahar DE. In vitro effects of adipose-derived stem cells on breast cancer cells harvested from the same patient. Ann Plast Surg 2016; 76 (Suppl. 03) S241-S245
- 31 Orbay H, Hinchcliff KM, Charvet HJ, Sahar DE. Fat graft safety after oncologic surgery: addressing the contradiction between in vitro and clinical studies. Plast Reconstr Surg 2018; 142 (06) 1489-1499
- 32 Kling RE, Mehrara BJ, Pusic AL. , et al. Trends in autologous fat grafting to the breast: a national survey of the American Society of Plastic Surgeons. Plast Reconstr Surg 2013; 132 (01) 35-46
- 33 Rigotti G, Marchi A, Stringhini P. , et al. Determining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstruction. Aesthetic Plast Surg 2010; 34 (04) 475-480
- 34 Kronowitz SJ, Mandujano CC, Liu J. , et al. Lipofilling of the breast does not increase the risk of recurrence of breast cancer: a matched controlled study. Plast Reconstr Surg 2016; 137 (02) 385-393
- 35 Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 2007; 119 (03) 775-785 , discussion 786–787
- 36 Hogge JP, Robinson RE, Magnant CM, Zuurbier RA. The mammographic spectrum of fat necrosis of the breast. Radiographics 1995; 15 (06) 1347-1356
- 37 Leibman AJ, Styblo TM, Bostwick III J. Mammography of the postreconstruction breast. Plast Reconstr Surg 1997; 99 (03) 698-704
- 38 Kneeshaw PJ, Lowry M, Manton D, Hubbard A, Drew PJ, Turnbull LW. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging. Breast 2006; 15 (01) 29-38
- 39 Yunus M, Ahmed N, Masroor I, Yaqoob J. Mammographic criteria for determining the diagnostic value of microcalcifications in the detection of early breast cancer. J Pak Med Assoc 2004; 54 (01) 24-29
- 40 Chala LF, de Barros N, de Camargo Moraes P. , et al. Fat necrosis of the breast: mammographic, sonographic, computed tomography, and magnetic resonance imaging findings. Curr Probl Diagn Radiol 2004; 33 (03) 106-126
- 41 U.S. Department of Health and Human Services; U.S. Food and Drug Administration. Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) from Adipose Tissue: Regulatory Considerations. Draft Guidance for Industry. Available at: https://www.ifats.org/assets/docs/01%20-%20Guidance%20-Draft%20Adipose%20Tissue.pdf . Accessed August 20, 2019
- 42 Johnson ML, Johnson L, Mahabir RC, Bernard R. Perspectives on the FDA draft guidances for use of adipose tissue. Aesthetic Surg J 2017; 37 (05) 622-625
- 43 U.S. Food and Drug Administration. Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal . Accessed August 20, 2019
- 44 U.S. Department of Health and Human Services; U.S. Food and Drug Administration. Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception. Guidance for Industry. Available at: https://www.fda.gov/media/89920/download . Accessed August 20, 2019